Frédéric V. Stanger

505 total citations
10 papers, 385 citations indexed

About

Frédéric V. Stanger is a scholar working on Molecular Biology, Molecular Medicine and Immunology. According to data from OpenAlex, Frédéric V. Stanger has authored 10 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Molecular Medicine and 2 papers in Immunology. Recurrent topics in Frédéric V. Stanger's work include Cancer therapeutics and mechanisms (3 papers), Signaling Pathways in Disease (3 papers) and Biochemical and Molecular Research (3 papers). Frédéric V. Stanger is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), Signaling Pathways in Disease (3 papers) and Biochemical and Molecular Research (3 papers). Frédéric V. Stanger collaborates with scholars based in Switzerland, United States and Denmark. Frédéric V. Stanger's co-authors include Christoph Dehio, Tilman Schirmer, Alexander Harms, A. Goepfert, Alexander Schmidt, Philipp Engel, Timo Glatter, Kenn Gerdes, Greg Mann and Tjaart de Beer and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and PLoS ONE.

In The Last Decade

Frédéric V. Stanger

10 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frédéric V. Stanger Switzerland 9 186 111 110 68 57 10 385
Khaled A. Aly Canada 11 252 1.4× 113 1.0× 143 1.3× 61 0.9× 15 0.3× 24 487
Felicity Alcock United Kingdom 16 534 2.9× 59 0.5× 177 1.6× 120 1.8× 28 0.5× 28 696
Hyeilin Ham United States 6 206 1.1× 193 1.7× 63 0.6× 35 0.5× 18 0.3× 7 442
Pierre‐Jean Matteï France 9 393 2.1× 110 1.0× 216 2.0× 70 1.0× 14 0.2× 9 670
Chacko Jobichen Singapore 15 231 1.2× 172 1.5× 168 1.5× 55 0.8× 11 0.2× 38 501
Audrey Dumont France 11 335 1.8× 197 1.8× 100 0.9× 141 2.1× 11 0.2× 13 686
Stephanie Barker United Kingdom 5 333 1.8× 67 0.6× 150 1.4× 102 1.5× 10 0.2× 8 623
Gareth McVicker United Kingdom 8 138 0.7× 146 1.3× 139 1.3× 69 1.0× 7 0.1× 17 384
Anita Kraiß Germany 9 229 1.2× 186 1.7× 115 1.0× 68 1.0× 9 0.2× 10 507
Robert Lintner United States 8 317 1.7× 38 0.3× 179 1.6× 89 1.3× 42 0.7× 8 488

Countries citing papers authored by Frédéric V. Stanger

Since Specialization
Citations

This map shows the geographic impact of Frédéric V. Stanger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric V. Stanger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric V. Stanger more than expected).

Fields of papers citing papers by Frédéric V. Stanger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric V. Stanger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric V. Stanger. The network helps show where Frédéric V. Stanger may publish in the future.

Co-authorship network of co-authors of Frédéric V. Stanger

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric V. Stanger. A scholar is included among the top collaborators of Frédéric V. Stanger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric V. Stanger. Frédéric V. Stanger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Mann, Greg, et al.. (2022). Biocatalytic assembly of chemically modified oligonucleotides. Tetrahedron Letters. 93. 153696–153696. 8 indexed citations
2.
Mann, Greg & Frédéric V. Stanger. (2020). A Bio-logical Approach to Catalysis in the Pharmaceutical Industry. CHIMIA International Journal for Chemistry. 74(5). 407–407. 5 indexed citations
3.
Stanger, Frédéric V., Björn M. Burmann, Alexander Harms, et al.. (2016). Intrinsic regulation of FIC-domain AMP-transferases by oligomerization and automodification. Proceedings of the National Academy of Sciences. 113(5). E529–37. 22 indexed citations
4.
Stanger, Frédéric V., Tjaart de Beer, David M. Dranow, et al.. (2016). The BID Domain of Type IV Secretion Substrates Forms a Conserved Four-Helix Bundle Topped with a Hook. Structure. 25(1). 203–211. 13 indexed citations
5.
Stanger, Frédéric V., Alexander Harms, Christoph Dehio, & Tilman Schirmer. (2016). Crystal Structure of the Escherichia coli Fic Toxin-Like Protein in Complex with Its Cognate Antitoxin. PLoS ONE. 11(9). e0163654–e0163654. 8 indexed citations
6.
Harms, Alexander, Frédéric V. Stanger, & Christoph Dehio. (2016). Biological Diversity and Molecular Plasticity of FIC Domain Proteins. Annual Review of Microbiology. 70(1). 341–360. 32 indexed citations
7.
Harms, Alexander, Frédéric V. Stanger, A. Goepfert, et al.. (2015). Adenylylation of Gyrase and Topo IV by FicT Toxins Disrupts Bacterial DNA Topology. Cell Reports. 12(9). 1497–1507. 83 indexed citations
8.
Stanger, Frédéric V., Christoph Dehio, & Tilman Schirmer. (2014). Structure of the N-Terminal Gyrase B Fragment in Complex with ADP⋅Pi Reveals Rigid-Body Motion Induced by ATP Hydrolysis. PLoS ONE. 9(9). e107289–e107289. 50 indexed citations
9.
Goepfert, A., Frédéric V. Stanger, Christoph Dehio, & Tilman Schirmer. (2013). Conserved Inhibitory Mechanism and Competent ATP Binding Mode for Adenylyltransferases with Fic Fold. PLoS ONE. 8(5). e64901–e64901. 31 indexed citations
10.
Engel, Philipp, A. Goepfert, Frédéric V. Stanger, et al.. (2012). Adenylylation control by intra- or intermolecular active-site obstruction in Fic proteins. Nature. 482(7383). 107–110. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026